| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 101.786 | 144.341 | 150.621 | 152.580 | 175.303 | 194.658 | 206.033 | 245.479 | 297.982 | 342.225 |
| Total Income - EUR | 101.787 | 144.340 | 150.621 | 152.580 | 175.443 | 202.283 | 206.033 | 247.523 | 298.300 | 342.113 |
| Total Expenses - EUR | 86.807 | 128.268 | 144.197 | 137.603 | 163.152 | 163.457 | 169.132 | 187.305 | 229.861 | 265.816 |
| Gross Profit/Loss - EUR | 14.980 | 16.072 | 6.424 | 14.977 | 12.291 | 38.826 | 36.901 | 60.219 | 68.439 | 76.298 |
| Net Profit/Loss - EUR | 12.200 | 13.307 | 4.113 | 13.452 | 10.536 | 36.949 | 34.973 | 57.793 | 65.520 | 66.236 |
| Employees | 18 | 21 | 22 | 19 | 20 | 20 | 19 | 19 | 20 | 18 |
Check the financial reports for the company - Diamed Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 487 | 404 | 320 | 239 | 160 | 85 | 12 | 0 | 18.720 | 12.475 |
| Current Assets | 76.720 | 73.150 | 35.814 | 40.958 | 42.338 | 57.832 | 56.544 | 81.002 | 114.984 | 133.804 |
| Inventories | 348 | 344 | 338 | 0 | 0 | 0 | 0 | 0 | 443 | 275 |
| Receivables | 75.835 | 58.282 | 35.767 | 30.132 | 41.124 | 51.969 | 52.688 | 78.956 | 109.926 | 133.289 |
| Cash | 537 | 14.523 | -292 | 10.826 | 1.214 | 5.863 | 3.857 | 2.046 | 4.615 | 240 |
| Shareholders Funds | 41.450 | 21.261 | 11.933 | 21.128 | 18.064 | 44.334 | 42.194 | 65.037 | 72.742 | 73.417 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 35.898 | 52.293 | 24.201 | 20.073 | 24.434 | 13.583 | 14.362 | 16.686 | 61.199 | 73.622 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
8110
|
|||||||||
Comments - Diamed Pharma Srl